These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 11196149)
1. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149 [TBL] [Abstract][Full Text] [Related]
2. Dietary factors and microsatellite instability in sporadic colon carcinomas. Diergaarde B; Braam H; van Muijen GN; Ligtenberg MJ; Kok FJ; Kampman E Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1130-6. PubMed ID: 14652271 [TBL] [Abstract][Full Text] [Related]
3. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Wolf LA; Terry PD; Potter JD; Bostick RM Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):676-83. PubMed ID: 17416757 [TBL] [Abstract][Full Text] [Related]
5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Nichols HB; Trentham-Dietz A; Hampton JM; Newcomb PA Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1212-8. PubMed ID: 15894674 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975 [TBL] [Abstract][Full Text] [Related]
8. Energy balance and colon cancer--beyond physical activity. Slattery ML; Potter J; Caan B; Edwards S; Coates A; Ma KN; Berry TD Cancer Res; 1997 Jan; 57(1):75-80. PubMed ID: 8988044 [TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and risk of colon and rectal cancer. Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789 [TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive use and risk of colorectal cancer. Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422 [TBL] [Abstract][Full Text] [Related]
11. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757 [TBL] [Abstract][Full Text] [Related]
12. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years. Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277 [TBL] [Abstract][Full Text] [Related]
13. CIMP status of interval colon cancers: another piece to the puzzle. Arain MA; Sawhney M; Sheikh S; Anway R; Thyagarajan B; Bond JH; Shaukat A Am J Gastroenterol; 2010 May; 105(5):1189-95. PubMed ID: 20010923 [TBL] [Abstract][Full Text] [Related]
14. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876 [TBL] [Abstract][Full Text] [Related]
16. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the canadian national enhanced cancer surveillance system. Frise S; Kreiger N; Gallinger S; Tomlinson G; Cotterchio M Ann Epidemiol; 2006 Dec; 16(12):908-16. PubMed ID: 16843679 [TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Samowitz WS; Curtin K; Ma KN; Schaffer D; Coleman LW; Leppert M; Slattery ML Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):917-23. PubMed ID: 11535541 [TBL] [Abstract][Full Text] [Related]
18. Menopause and stroke and the effects of hormonal therapy. Lobo RA Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669 [TBL] [Abstract][Full Text] [Related]
19. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group. Brinton LA; Hoover RN Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913 [TBL] [Abstract][Full Text] [Related]
20. Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Elliott AM; Hannaford PC Contraception; 2006 Apr; 73(4):331-5. PubMed ID: 16531161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]